These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 12467745

  • 1. An evaluation of leukaemia inhibitory factor as a potential therapeutic agent in the treatment of muscle disease.
    White JD, Davies M, McGeachie J, Grounds MD.
    Neuromuscul Disord; 2002 Dec; 12(10):909-16. PubMed ID: 12467745
    [Abstract] [Full Text] [Related]

  • 2. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse.
    Austin L, Bower JJ, Bennett TM, Lynch GS, Kapsa R, White JD, Barnard W, Gregorevic P, Byrne E.
    Muscle Nerve; 2000 Nov; 23(11):1700-5. PubMed ID: 11054748
    [Abstract] [Full Text] [Related]

  • 3. Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury.
    Matecki S, Guibinga GH, Petrof BJ.
    Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R961-8. PubMed ID: 15191902
    [Abstract] [Full Text] [Related]

  • 4. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse.
    Kurek J, Bower J, Romanella M, Austin L.
    Neurosci Lett; 1996 Jul 19; 212(3):167-70. PubMed ID: 8843099
    [Abstract] [Full Text] [Related]

  • 5. Inspiratory loading does not accelerate dystrophy in mdx mouse diaphragm: implications for regenerative therapy.
    Krupnick AS, Zhu J, Nguyen T, Kreisel D, Balsara KR, Lankford EB, Clark CC, Levine S, Stedman HH, Shrager JB.
    J Appl Physiol (1985); 2003 Feb 19; 94(2):411-9. PubMed ID: 12531909
    [Abstract] [Full Text] [Related]

  • 6. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation.
    White JD, Bower JJ, Kurek JB, Austin L.
    Muscle Nerve; 2001 May 19; 24(5):695-7. PubMed ID: 11317281
    [Abstract] [Full Text] [Related]

  • 7. The role of leukemia inhibitory factor in skeletal muscle regeneration.
    Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L.
    Muscle Nerve; 1997 Jul 19; 20(7):815-22. PubMed ID: 9179153
    [Abstract] [Full Text] [Related]

  • 8. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle.
    Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L.
    Muscle Nerve; 1996 Oct 19; 19(10):1291-301. PubMed ID: 8808655
    [Abstract] [Full Text] [Related]

  • 9. Controlled release of leukaemia inhibitory factor (LIF) to tissues.
    Austin L, Bower JJ, Kurek JB, Muldoon CM.
    Growth Factors; 1997 Oct 19; 15(1):61-8. PubMed ID: 9401818
    [Abstract] [Full Text] [Related]

  • 10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS.
    Exp Physiol; 2014 Apr 19; 99(4):675-87. PubMed ID: 24443351
    [Abstract] [Full Text] [Related]

  • 11. Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice.
    Stupka N, Michell BJ, Kemp BE, Lynch GS.
    Neuromuscul Disord; 2006 May 19; 16(5):337-46. PubMed ID: 16621557
    [Abstract] [Full Text] [Related]

  • 12. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF, Mantuano P, Cozzoli A, Sanarica F, Massari AM, Conte E, Fonzino A, Giustino A, Rolland JF, Quaranta A, De Bellis M, Camerino GM, Grange RW, De Luca A.
    J Appl Physiol (1985); 2017 Apr 01; 122(4):828-843. PubMed ID: 28057817
    [Abstract] [Full Text] [Related]

  • 13. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
    Lynch GS, Hinkle RT, Faulkner JA.
    Neuromuscul Disord; 2001 Mar 01; 11(2):192-6. PubMed ID: 11257477
    [Abstract] [Full Text] [Related]

  • 14. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.
    Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS.
    Am J Pathol; 2002 Dec 01; 161(6):2263-72. PubMed ID: 12466140
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle.
    White JD, Davies M, Grounds MD.
    Cell Tissue Res; 2001 Oct 01; 306(1):129-41. PubMed ID: 11683174
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.
    Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL.
    J Cell Biol; 2002 Apr 01; 157(1):137-48. PubMed ID: 11927606
    [Abstract] [Full Text] [Related]

  • 20. In vivo treatment with the NF-κB inhibitor ursodeoxycholic acid (UDCA) improves tension development in the isolated mdx costal diaphragm.
    Carlson CG, Potter R, Yu V, Luo K, Lavin J, Nielsen C.
    Muscle Nerve; 2016 Mar 01; 53(3):431-7. PubMed ID: 26148297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.